IOVA
- Iovance Biotherapeutics, Inc.
()
Overview
Company Summary
Iovance Biotherapeutics, Inc. is a biotechnology company that specializes in developing and commercializing personalized immunotherapies for the treatment of various types of cancers. The company focuses on harnessing the power of a patient's immune system to fight cancer effectively.
Iovance Biotherapeutics primarily utilizes a technology known as tumor-infiltrating lymphocytes (TIL) therapy. This therapy involves the extraction of tumor-infiltrating white blood cells from a patient's tumor tissue. These TILs are then cultured and expanded in the lab to increase their numbers before being infused back into the patient.
The goal of TIL therapy is to enhance the patient's immune response against cancer cells. These TILs have the ability to target and eliminate cancerous cells, thereby potentially shrinking tumors and improving patient outcomes.
Iovance Biotherapeutics has a particular focus on developing TIL therapies for the treatment of solid tumors, including melanoma, cervical cancer, non-small cell lung cancer, and head and neck cancer. Their research and clinical trials involve evaluating the efficacy and safety of TIL therapy across various stages of cancer.
Overall, Iovance Biotherapeutics aims to advance the field of immunotherapy and bring innovative treatment options to patients with limited therapeutic options for their cancer types.